NRG NCORP is soliciting LOIs in preparation for the next NCORP pilot grant RFA. Anyone interested in applying must submit a Letter of Intent (LOI) by October 11, 2024. Read more: conta.cc/478d0e8#

The NRG Protocol Support Committee (PSC) released an #NRG2024 meeting wrap up article in the August NRG newsletter. Read it here: ow.ly/GGOQ50SWR0H

ICYMI - we just activated NRG-BN013 (Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases). Read more: conta.cc/3MmoqBt Rupesh Kotecha @theCTSU Miami Cancer Institute Research

September is #ProstateCancerAwarenessMonth. Prostate cancer mainly affects men over the age of 50, with 1 in 8 men being diagnosed in their lifetime. Visit National Cancer Institute website to learn more about prevention, screening, statistics, and research. cancer.gov/types/prostate

September is #GynecologicCancerAwarenessMonth, which includes cervical, ovarian, uterine/endometrial, vaginal, & vulvar cancer. According to National Cancer Institute, more than 108,000 women in the US are expected to be diagnosed in 2024. AACR ow.ly/ymt650TaNCC

September is #OvarianCancerAwarenessMonth. Ovarian Cancer Research Alliance is the leading organization in the world fighting ovarian cancer on all fronts while supporting patients and their families. Learn more: ocrahope.org

All NRG Oncology locations are closed today in observance of the Labor Day holiday.

NRG Oncology Weekly Broadcast for September 3, 2024: conta.cc/3yUkXHl

I look forward to opening/offering this trial. Pretty easy logistics and a pure #RadOnc question. Also a rare and important ask: "are more fractions better?"

Welcome to SOROCk’N Wednesday & September #OvarianCancerAwarenessMonth! One key aspect of ovarian cancer awareness is knowledge of cancer prevention. The SOROCk trial aims to prevent ovarian cancer in patients in BRCA1 mutations. #BRCA1 #ovariancancerprevention #NRGcc008

DEADLINE APPROACHING - Sept 11: NRG Oncology Seeks Candidates for Theranostics Subcommittee Chair and Vice Chair. Read more: ow.ly/mjEe50TfTov

The NRG-GU012 SAMURAI trial is open to enrollment for patients with metastatic renal cell cancer. Dr. William Hall William A Hall, MD explains more about the study in this video: youtube.com/watch?v=pB3QR3… Rana McKay, MD, FASCO Paul Nguyen

September is #ProstateCancerAwarenessMonth Which groups of men are at a higher risk for prostate #cancer? Find out the risk factors: bit.ly/3Vlyekj

New #RedJournal article from @nrgonc, Long-term results of bladder preservation with twice-daily radiation plus 5-Flourouracil/Cisplatin or daily radiation plus gemcitabine for MIBC. #radonc tinyurl.com/redcoen

The NRG-BR008 HERO study is trying to determine if HER2-targeted tx w/o radiation has the same chance of preventing #breastcancer returning compared to HER2-targeted tx w/radiation. Amendments to ease enrollment & treatment requirements coming. ow.ly/o3yh50ThoJy

September issue of @FORTEStudy Fridays is here! conta.cc/3ZeM8Hs

PRESS RELEASE: NRG Oncology Study Results Indicate that Radiation and Chemotherapy After Surgery Could be a Viable Alternative to Radical Cystectomy for Patients with Recurrent Bladder Cancer - Read the release: ow.ly/ClWJ50ThEF7

Now enrolling! NRG-CC012CD: Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment. Learn more: nrgoncology.org/cc012cd #NCORP #CCDR

Not a football fan? Check out the NRG Oncology Podcast instead, created to allow everyone to listen to topics regarding cancer care, trial barriers & a variety of other topics. Tune in and follow us on Spotify, Apple Podcasts, and YouTube. Stephen Chun @Lauren_Henke

ONE week away from our next "The NRG Oncology Podcast" episode! We sit w/ Dr. Mannel, NRG Group Chair & Director of the OU Health Stephenson Cancer Center to discuss #GynOnc, GYN health disparities & early career investigators OU Health Stephenson Cancer Center OU Health Stephen Chun Lauren Henke, MD, MSCI